Clinical Trials Logo

Clinical Trial Summary

1. Protocol Summary Title: SHARP: Small Hyperplastic and Adenomatous Reliability Protocol Purpose: To compare the accuracy of NBI-in vivo differentiation between hyperplastic and adenomatous <10 mm polyps with that of histology in an European multi-center study. To assess variability among endoscopists in NBI accuracy. We also aim to assess whether this technology impacts the appropriateness of surveillance intervals.

Design: 1) Before starting the patient enrollment, the participating endoscopists will attend an internet-based training program on the in vivo differentiation between hyperplastic and adenomatous polyps. Following this course, a qualifying examination will be required for each endoscopist to be included.

2) Patients who are scheduled for screening or diagnostic colonoscopy will be considered for inclusion. Patients with at least one histologically verified <10 mm polyp will be included. In order to measure NBI feasibility, each included polyp will be in vivo assessed by NBI in order to rank between a high- and a low- level of diagnostic confidence, and thereafter will be sent for histological assessment. NBI- and histological accuracy in differentiating between hyperplastic and adenomatous lesions will be analyzed and compared, in order to assess the NBI-sensitivity and specificity. The primary outcomes are to measure the NBI feasibility and accuracy in the study population, and to assess the variability among the endoscopists. Secondary outcome measures will be a cost analysis on how much savings would be achieved by not referring NBI-diagnosed hyperplastic polyps to histology, and a clinical inference on how many patients would be scheduled for an inappropriate post-polypectomy follow up, when follow up schedule is based on NBI classification. Clinical results will be analyzed using various statistical measures of significance.

Clinical Site Locations: 10 European centres with NBI-technology

1 NBI-expert endoscopist for each centre Enrollment: 160 small (<10 mm) polyps at each site Study technology: NBI-Olympus without optical magnification Risk: Non-interventional study.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT01675752
Study type Observational
Source Istituto Clinico Humanitas
Contact
Status Completed
Phase N/A
Start date May 2011
Completion date July 2012

See also
  Status Clinical Trial Phase
Completed NCT00828984 - Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal Cancer Phase 2
Completed NCT01124266 - Endoscopy Nurse Participation in Adenoma Detection Rate During Colonoscopy Phase 4
Completed NCT01133041 - Comparative Study of Postprocessing Imaging Systems for Diminutive Colonic Polyps Phase 4
Completed NCT01656746 - Single Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease N/A
Completed NCT01312467 - Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI Phase 2
Completed NCT00754494 - Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma Phase 2
Completed NCT00614770 - Narrow Band Imaging Colon Polyp Study N/A
Completed NCT00983580 - Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer Phase 2
Recruiting NCT00613262 - A Prospective, Single Blinded Study for Predicting Colon Polyp Histology With Narrow Band Imaging N/A